CLN3 and Mental deterioration: This finding remained when analysis was restricted to patients with genetically confirmed classical CLN3 disease (n = 73) (mean age at onset of visual deterioration (n = 50) and cognitive decline (n = 14): 6.2 years and 7.1 years, respectively).